DR. CHRISTOPHER LAFARGUE M.D. NPI 1306286166

NPI Information

  • NPI: 1306286166
  • Provider Name: DR. CHRISTOPHER LAFARGUE, M.D.
  • Classification: Obstetrics & Gynecology - 207VX0201X
  • Specialization: Gynecologic Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 500 S HENDERSON ST STE 300
    FORT WORTH, TX
    ZIP 76104
  • Phone: (817) 413-1500

Map and Directions

Get Directions

NPI Details

DR. Christopher Lafargue, M.D. is a gynecologic oncology obstetrics gynecology in Fort Worth, TX with 13 years of experience. The provider is an obstetrician/gynecologist who provides consultation and comprehensive management of patients with gynecologic cancer, including those diagnostic and therapeutic procedures necessary for the total care of the patient with gynecologic cancer and resulting complications. DR. Christopher Lafargue, M.D. NPI is 1306286166. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: NEW YORK MEDICAL COLLEGE
Graduation Year:2013

The provider's business location address is:

500 S HENDERSON ST STE 300
FORT WORTH, TX
ZIP 76104-154
Phone: (817) 413-1500
Fax: (817) 413-1499

The NPI 1306286166 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, pembrolizumab, 1 mg (HCPCS:J9271)
  • Injection, paclitaxel, 1 mg (HCPCS:J9267)
  • Injection, fosaprepitant, 1 mg (HCPCS:J1453)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Injection, granisetron hydrochloride, 100 mcg (HCPCS:J1626)
  • Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Injection, carboplatin, 50 mg (HCPCS:J9045)
  • Injection, zoledronic acid, 1 mg (HCPCS:J3489)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Immunologic analysis for detection of tumor antigen, quantitative; ca 125 (HCPCS:86304)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Irrigation of implanted venous access drug delivery device (HCPCS:96523)
  • Unclassified drugs (HCPCS:J3490)
  • Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
  • Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
  • Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
  • Infusion into a vein for hydration, each additional hour (HCPCS:96361)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Immunologic analysis for detection of tumor antigen, quantitative; ca 19-9 (HCPCS:86301)
  • Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
  • Melanoma (skin cancer) excision (HCPCS:NAN03)

The enumeration date for this NPI number is 6/26/2013 and was last updated on 9/14/2021.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1390200000XStudent in an Organized Health Care Education/Training ProgramCALIFORNIANo
2207VX0201XObstetrics & GynecologyGynecologic OncologyS0717TEXASYes

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.

No. Other Provider Identifier Other Provider Identifier Type Other Provider Identifier State Other Provider Identifier Issuer
1399144003MEDICAIDTEXAS

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.